Impact of Stigma in Siblings of Young Patients With Schizophrenic Disorders (STIG)

May 28, 2020 updated by: Januel
Impact of stigma on the empathy and quality of life of people with schizophrenic disorders and their siblings.

Study Overview

Status

Unknown

Conditions

Study Type

Observational

Enrollment (Anticipated)

198

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years to 35 years (Adult)

Accepts Healthy Volunteers

N/A

Genders Eligible for Study

All

Sampling Method

Non-Probability Sample

Study Population

people with schizophrenic disorders and the subjective sense of stigma and siblings of people with schizophrenic disorders

Description

Inclusion Criteria:

Inclusion Criteria for the Person with Schizophrenic Disorder

  1. Aged between 18 and 35.
  2. Medical follow-up in progress
  3. DSM-5 diagnosis of Schizophrenia Spectrum Disorder
  4. Reading and understanding the information and non-opposition form
  5. Person affiliated to a social protection scheme or beneficiary of State Medical Aid
  6. Volunteer mastering the French language

Exclusion Criteria:

Non-inclusion criteria for the person with schizophrenic disorders:

1. Clinical condition incompatible with testing 2. Current or less than one month's commitment to another research protocol 3. A person who is subject to a safeguard measure of justice 4 A person of full age under guardianship 5. Minor patients with mental disorders 6. Pregnant or breastfeeding women Version 1.2 date 19-05-2020 7. A person in situations of social fragility (persons deprived of liberty by a judicial or administrative decision, hospitalized persons) 8. Persons incapable or unable to give consent

Inclusion Criteria:

Inclusion criteria for a sibling member:

  1. Age of 16 years or older
  2. Volunteer with a sibling included in the study with a diagnosis of schizophrenia according to DSM-5.
  3. Reading and understanding the information and non-opposition form
  4. Volunteer affiliated to a social protection scheme or beneficiary of State Medical Aid
  5. Volunteer mastering the French language

Criteria for non-inclusion of siblings:

  1. Clinical condition incompatible with testing
  2. Current or less than one month's commitment to another research protocol
  3. Brother or sister subject to a measure of safeguard of justice 4 Brother or sister under curatorship

5. Brother or sister with mental health problems 6. Minor siblings under 16 years of age 7. A pregnant or nursing sister 8. Brother or sister in situations of social fragility (Persons deprived of liberty by a judicial or administrative decision, hospitalized persons) 9.Brother or sister incapable or unable to give consent

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Observational Models: Cohort
  • Time Perspectives: Cross-Sectional

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Internalized Stigma of Mental Illness Scale
Time Frame: 1 hour and half
for people with schizophrenic disorders
1 hour and half

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

Januel

Investigators

  • Principal Investigator: Davtian Hélène, Doctor, Les Funambules - Falret

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Anticipated)

May 25, 2020

Primary Completion (Anticipated)

December 25, 2020

Study Completion (Anticipated)

May 25, 2022

Study Registration Dates

First Submitted

May 28, 2020

First Submitted That Met QC Criteria

May 28, 2020

First Posted (Actual)

June 2, 2020

Study Record Updates

Last Update Posted (Actual)

June 2, 2020

Last Update Submitted That Met QC Criteria

May 28, 2020

Last Verified

May 1, 2020

More Information

Terms related to this study

Additional Relevant MeSH Terms

Other Study ID Numbers

  • 10477M-STIG

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on The Impact of Stigma on the Quality of Life of People With Schizophrenic Disorders and Their Siblings

Search Similar Trials

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Burundi

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations

Subscribe